President Donald Trump and other federal officials are claiming that deals the administration has struck with pharmaceutical companies are “rescuing state budgets” or helping to “save Medicaid” by saving the program tens of billions of dollars on prescription drugs over a decade. But experts say there are many unanswered questions about the scope of those deals that could limit the potential savings, including how many drugs they actually cover.
Issues: drug prices
FactChecking Trump’s Midterm Convention Speech
The Shaky Assumptions Behind Trump’s Over $500 Billion in Projected Drug Savings
FactChecking Trump’s State of the Union Address
In the first State of the Union address of his second term, President Donald Trump proclaimed that “our nation is back, bigger, better, richer and stronger than ever before.” But our review of his speech found that he distorted a number of facts about the state of the economy, health care, immigration and other topics.
Trump Misleads on Drug Pricing Deals
President Donald Trump has said that Americans are now paying or will pay “the lowest price anywhere in the world for drugs,” thanks to the administration’s negotiations with pharmaceutical companies. The administration has announced discounted cash prices for a small number of brand-name drugs. There isn’t evidence Trump’s deals so far have led to broad decreases in drug prices, nor is it certain they will in the future.
FactChecking Trump’s Rapid-Fire Prime-Time Address
Q&A on Trump’s Prescription Drug Pricing Executive Order
Trump Order Didn’t Reverse All of Biden’s Measures to Lower Drug Costs
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for lowering drug costs. Trump’s action didn’t affect the caps on seniors’ drug costs or Medicare price negotiations that Biden signed into law. But social media posts have wrongly claimed otherwise.









